America's pharmaceutical industry is facing a 'monkey problem' & reason is China
America's pharmaceutical industry is currently experiencing a significant shortage of laboratory monkeys for research purposes. Rising costs and import restrictions have exacerbated the situation since the export ban from China in 2020. While laboratories have sought alternatives from Cambodia, ethical concerns about animal sourcing have emerged. A startup, backed by Joe Lonsdale, plans to establish a...
Key Takeaways
- America's pharmaceutical industry is currently experiencing a significant shortage of laboratory monkeys for research purposes.
- Rising costs and import restrictions have exacerbated the situation since the export ban from China in 2020.
- While laboratories have sought alternatives from Cambodia, ethical concerns about animal sourcing have emerged.
America's pharmaceutical industry is currently experiencing a significant shortage of laboratory monkeys for research purposes. Rising costs and import restrictions have exacerbated the situation since the export ban from China in 2020. While laboratories have sought alternatives from Cambodia, ethical concerns about animal sourcing have emerged. A startup, backed by Joe Lonsdale, plans to establish a breeding facility to alleviate supply constraints.
Original Publisher Attribution
This summary was curated from Times of India.